Randomized phase III trial comparing adjuvant oral UFT [tegafur/uracil]/LV [leucovorin; folinic acid] to 5-FU [fluorouracil]/l-LV in stage III colorectal cancer (JCOG-0205-MF)

Trial Profile

Randomized phase III trial comparing adjuvant oral UFT [tegafur/uracil]/LV [leucovorin; folinic acid] to 5-FU [fluorouracil]/l-LV in stage III colorectal cancer (JCOG-0205-MF)

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary) ; Fluorouracil
  • Indications Colon cancer; Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Mar 2013 New source identified and integrated (University Hospital Medical Information Network - Japan, C000000193).
    • 05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
    • 15 Dec 2009 Actual patient number (1101) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top